How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

690 results for

Dysuria in Children

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

621. What evidence is there for advising patients with UTI to drink more fluids?

including images, videos, patient information leaflets, educational courses and news. For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com What evidence is there for advising patients with UTI to drink more fluids? Prodigy has produced three guidelines (1-3) on UTI that cover men, women and children. In each of the guidelines Prodigy states: “ Increasing fluid intake (...) is common advice but is controversial and unproven. Theoretically it might help to 'wash out' the bladder but it can distress people with dysuria. Answered 23 June 2006 Follow us: © 2019 Trip Database Ltd. company number 04316414. Trip is proud to be made in the UK.

2006 TRIP Answers

622. Should an asymptomatic woman who has had a total hysterectomy be screened for chlamydia if her partner has a diagnosis of NSU. If found to be a carrier should she be treated?

GP Microbiology Laboratory Use Group, 2002]: - Sexual partners of those with proven or suspected chlamydial infection - All women with another sexually transmitted infection, including genital warts - All women undergoing termination of pregnancy - All women attending genito-urinary medicine clinics - Mothers of infants with chlamydial conjunctivitis or pneumonitis - Semen and egg donors - Prior to inserting an intrauterine contraceptive device in women considered to be at risk of sexually (...) Can Still Acquire Chlamydialor Gonococcal Urethritis; Several Testing Options Are Available. After hysterectomy, the urethra is the usual site of infection with C trachomatis or N gonorrhoeae. Infected patients are usually asymptomatic, although some will present with an acute urethral syndrome (dysuria and frequency without significant bacteriuria)….” With regard to treatment the same CKS guideline reports on the National Chlamydia Screening Programme (NCSP), reporting: “The NCSP aims to control

2007 TRIP Answers

623. In pre-pubertal girls who present with vaginal irritation or discharge, should a swab always be taken and what treatment should be given initially, as I realise that thrush is not usually the cause?

of the genital area, are essential. Swabs of vaginal secretions from the introitus should be obtained for gram staining, microscopy, and culture. The presence of leucocytes increased the likelihood of finding bacterial pathogens in one study.In suspected cases of threadworm infection, a "sellotape test" may be undertaken, even though it is said to have a relatively low yield.Urine microscopy and culture may be helpful in children with dysuria. “ Concerning the treatment of patients presenting with symptoms (...) @tripdatabase.com In pre-pubertal girls who present with vaginal irritation or discharge, should a swab always be taken and what treatment should be given initially, as I realise that thrush is not usually the cause? We found no guidelines on the management of vulvovaginitis in children. Joishy et al considered the need for treating prepubescent patients presenting with vulvovaginitis in an article published in the BMJ last year, in which they note: “ A detailed history and examination, including inspection

2006 TRIP Answers

624. Does Implementing a Urinanylsis Protocol Based on Symptoms Decrease Length of Stay in the Emergency Department?

. For general information, Layout table for eligibility information Ages Eligible for Study: 16 Years to 65 Years (Child, Adult, Older Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: Yes Criteria Inclusion Criteria: patients between 16 and 65 years of age complaining of any of the following: dysuria, hematuria, urinary frequency, urinary urgency Exclusion Criteria: any person less than 16 or greater than 65 years of age, history of kidney disease or transplant, foley catherization within

2007 Clinical Trials

625. Cipro® XR in Therapeutic Response and Activity (eXtRa)

Information provided by (Responsible Party): Bayer Study Details Study Description Go to Brief Summary: The primary objective of this clinical trial was to determine the time to improvement of the signs and symptoms (eg, dysuria, frequency, urgency, gross hematuria, suprapubic pain, hesitancy, low back pain) of acute, uncomplicated, symptomatic, lower UTIs in women treated with Cipro XR 500 mg once daily for 3 days. Condition or disease Intervention/treatment Phase Urinary Tract Infection Drug: Cipro XR (...) links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Experimental: Arm 1 Drug: Cipro XR (Ciprofloxacin, BAYQ3939) 3 tablets of Cipro XR 500 mg and were instructed to take 1 tablet per day for 3 days. Outcome Measures Go to Primary Outcome Measures : Time to improvement of the signs and symptoms (eg, dysuria, frequency, urgency, gross hematuria, suprapubic pain, hesitancy, low back pain) of acute, uncomplicated

2008 Clinical Trials

626. NGU: Doxycycline (Plus or Minus Tinidazole) Versus Azithromycin (Plus or Minus Tinidazole)

information, Layout table for eligibility information Ages Eligible for Study: 16 Years to 45 Years (Child, Adult) Sexes Eligible for Study: Male Accepts Healthy Volunteers: No Criteria Inclusion Criteria: Male, 16 to 45 years old. Symptoms of non-gonococcal urethritis (NGU), including urethral discharge and/or dysuria for less than or equal to 14 days, or urethral discharge on exam. Urethral smear with greater than or equal to 5 polymorphonuclear leukocytes (PMNs) per 3-5 oil immersion fields. Willing

2006 Clinical Trials

627. Genetic Studies in Interstitial Cystitis

: Layout table for additonal information Responsible Party: Louis Kunkel, Professor of Genetics and Pediatrics, Harvard Medical School, Boston Children’s Hospital ClinicalTrials.gov Identifier: Other Study ID Numbers: 04-11-160 91208 ( Other Grant/Funding Number: Broad Institute ) First Posted: October 18, 2006 Last Update Posted: October 9, 2018 Last Verified: October 2018 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: Yes Plan Description: Data from individual participants (...) validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT00389142 Recruitment Status : Recruiting First Posted : October 18, 2006 Last Update Posted : October 9, 2018 See Sponsor: Boston Children’s Hospital Information provided by (Responsible Party): Louis

2006 Clinical Trials

628. Study to Compare Safety and Immunogenicity of Commercial Scale Consistency Lots of Herpes Simplex Vaccine

research staff using the contacts provided below. For general information, Layout table for eligibility information Ages Eligible for Study: 10 Years to 17 Years (Child) Sexes Eligible for Study: Female Accepts Healthy Volunteers: Yes Criteria Inclusion Criteria: Healthy female between, and including, 10 and 17 years of age at the time of the first vaccination. Seronegative for HSV-1 and HSV-2 at screening Written informed assent obtained from the subject and written informed consent obtained from (...) clinical signs or symptoms of oro-labial (cold sores), genital or non-genital HSV disease, such as swelling, papules, vesicles, pustules, ulcers, crusts, fissures, erythema, discharge, pain, burning, itching, tingling, or dysuria. Previous vaccination against herpes. History of erythema multiforme. Use of any investigational or non-registered drug or vaccine other than the study vaccine(s) within 30 days preceding the first dose of study vaccine, or planned use during the study period. Planned

2005 Clinical Trials

629. Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old

and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Layout table for eligibility information Ages Eligible for Study: 10 Years to 17 Years (Child) Sexes Eligible for Study: Female Accepts Healthy Volunteers: Yes Criteria Inclusion Criteria: Subjects who the investigator believes that can and will comply with the requirements of the protocol should (...) the first dose of study vaccine, or planned use during the study period. Pregnant or lactating female. Female planning to become pregnant or likely to become pregnant during the first eight months of the study (months 0-8). Any previous confirmed history of, or current clinical signs or symptoms of, oro labial herpes (cold sores), herpetic whitlow or genital herpes disease, such as swelling, papules, vesicles, pustules, ulcers, crusts, fissures, erythema, discharge, dysuria or pain, burning, itching

2005 Clinical Trials

630. Genitourinary complications of epidermolysis bullosa. (Abstract)

Genitourinary complications of epidermolysis bullosa. Epidermolysis bullosa is a rare inherited bullous disorder of the skin that occasionally involves the urinary tract. We describe a child with a history of epidermolysis bullosa who presented with hematuria, urgency, and dysuria. On radiographic investigation, bladder wall lesions were found. On cystoscopy, these were bullous lesions on the urinary bladder that at biopsy were shown to have inflammatory changes without evidence of malignancy

2007 Urology

631. Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso. Full Text available with Trip Pro

of this study was to assess the safety and efficacy of two MB-based malaria combination therapies, MB-artesunate (AS) and MB-amodiaquine (AQ), compared to the local standard of care, AS-AQ, in Burkina Faso.Open-label randomised controlled phase II study in 180 children aged 6-10 years with uncomplicated falciparum malaria in Nouna, north-western Burkina Faso. Follow-up was for 28 days and analysis by intention-to-treat. The treatment groups were similar in baseline characteristics and there was only one (...) loss to follow-up. No drug-related serious adverse events and no deaths occurred. MB-containing regimens were associated with mild vomiting and dysuria. No early treatment failures were observed. Parasite clearance time differed significantly among groups and was the shortest with MB-AS. By day 14, the rates of adequate clinical and parasitological response after PCR-based correction for recrudescence were 87% for MB-AS, 100% for MB-AQ (p = 0.004), and 100% for AS-AQ (p = 0.003). By day 28

2008 PloS one Controlled trial quality: predicted high

632. A 16-year-old boy with acute urinary retention. (Abstract)

A 16-year-old boy with acute urinary retention. Urinary retention can be described as the inability to void volitionally despite an adequate volume of urine in the bladder. It is a common complaint in adults, especially among elderly males with benign prostatic hyperplasia. Children, in contrast, are more likely to have voluntary retention of urine due to urethral irritation or dysuria. Gently massaging the suprapubic region while the child is in a warm bath often relieves the retention

2007 Pediatric Emergency Care

633. Does the less aggressive multimodal approach of treating bladder-prostate rhabdomyosarcoma preserve bladder function? (Abstract)

Does the less aggressive multimodal approach of treating bladder-prostate rhabdomyosarcoma preserve bladder function? The treatment of bladder-prostate rhabdomyosarcoma has evolved into multimodal therapy, including chemotherapy, radiotherapy and organ sparing surgery with bladder preservation. We investigated bladder function in children who underwent multimodal therapy at our institution and retained the original bladder for at least 6 months after treatment ended.We evaluated 8 children (...) with bladder-prostate rhabdomyosarcoma treated at our institution between 1999 and 2003 according to inclusion criteria. All patients underwent history, physical examination and urodynamic study at least 6 months after completion of treatment (range 6 to 39 months).All patients were treated following the same chemotherapy and radiotherapy scheme. Three patients (37.5%) were asymptomatic and had normal urodynamic studies, and 1 had only dysuria (this patient later underwent continent urinary diversion

2005 Journal of Urology

634. Long-term effects of dextranomer endoscopic injections for the treatment of urinary incontinence: an update of a prospective study of 61 patients. (Abstract)

Long-term effects of dextranomer endoscopic injections for the treatment of urinary incontinence: an update of a prospective study of 61 patients. To treat sphincteric deficiency in children endoscopic bladder neck injections may avoid or salvage more complex procedures. A prospective study to assess the efficacy of bladder neck injections of dextranomer based implants (Deflux(R)) was done in a 7-year period in 61 patients.From September 1997 to September 2004 we enrolled in the study 41 males (...) ). Postoperative complications were temporary dysuria in 2 patients nonfebrile urinary tract infection in 10, orchid-epididymitis in 1 and urinary retention with pyelonephritis in 1. The incidence of dryness or improvement during followup was 79% (48 of 61 patients) at 1 month, 56% (31 of 55) at 6 months, 52% (24 of 46) at 1 year, 51% (18 of 35) at 2 years, 52% (16 of 31) at 3 years, 48% (12 of 25) at 4 years, 43% (9 of 21) at 5 years, 36% (4 of 11) at 6 years and 40% (2 of 5) at 7 years. The success rate

2006 Journal of Urology

635. Urogenital symptoms of postmenopausal women in Turkey. (Abstract)

by SPSS 10.0. The chi-square test was the statistical test of choice.The mean age of participants was 58.64 +/- 8.14 years. The mean age of menopause was 47.21 +/- 4.36 years. Urinary frequency was found to be the most common postmenopausal urogenital symptom (16.5%), followed by stress incontinence (10.4%), dyspareunia (10%), and vaginal dryness (9.6%). Risk factors investigated were found not to affect the prevalence of the vaginal symptoms in postmenopausal women. Dysuria was found to be more (...) common in women with diabetes mellitus (P = 0.022) and in women who had given birth to more children (P = 0.018). Stress incontinence was more common in those 60 years of age or older (P = 0.03), in those who had been in the postmenopausal period for more than 20 years (P = 0.01), and in those who had more than three pregnancies (P = 0.047) or who had given birth to more than three children (P = 0.011). Diabetes mellitus (P = 0.001) and use of hormone therapy (P = 0.001) significantly increased

2007 Menopause

636. infections of the urinary tract in children

in voided urine (studies on urine specimens from large numbers of hospital patients confirm that a pure growth of 10^5 organisms per ml or greater is indicative of infection (1) about 2% of boys and 8% or more of girls will develop a urinary tract infection during childhood Note that in some children, especially boys, the child may not retain urine in the bladder for a long enough period for multiplication to a pure growth of 10^5 organisms per ml to occur. In these cases a pure growth of 10^4-10^5 (...) organisms may indicate infection. NICE note that clinical features suggestive of UTI, in a child less than 5 years, are: vomiting poor feeding lethargy irritability abdominal pain or tenderness urinary frequency or dysuria offensive urine or haematuria NICE now state if suspected UTI is an infants younger than 3 months then: there are concerns about sepsis in infants under 3 months with suspected UTI, and usual practice is referral rather than the GP managing symptoms. So the committee recommended

2010 GP Notebook

637. urinary tract infection (UTI) in children

urine (studies on urine specimens from large numbers of hospital patients confirm that a pure growth of 10^5 organisms per ml or greater is indicative of infection (1) about 2% of boys and 8% or more of girls will develop a urinary tract infection during childhood Note that in some children, especially boys, the child may not retain urine in the bladder for a long enough period for multiplication to a pure growth of 10^5 organisms per ml to occur. In these cases a pure growth of 10^4-10^5 organisms (...) may indicate infection. NICE note that clinical features suggestive of UTI, in a child less than 5 years, are: vomiting poor feeding lethargy irritability abdominal pain or tenderness urinary frequency or dysuria offensive urine or haematuria NICE now state if suspected UTI is an infants younger than 3 months then: there are concerns about sepsis in infants under 3 months with suspected UTI, and usual practice is referral rather than the GP managing symptoms. So the committee recommended that all

2010 GP Notebook

638. Recurrent Urinary Tract Infection

available. Children with a high risk of serious illness and/or younger than 3 months should be referred immediately to secondary care. This should be assessed in accordance with NICE guidance "Feverish illness in children". [ ] Do not delay treatment if the sample cannot be obtained and the infant or child is at high risk of serious illness. Treat each episode of acute UTI the same as a first episode. If a second episode occurs within a year, check for anatomical abnormalities, voiding problems (...) urinary tract surgery. Immunocompromise. In children [ ] Any condition that leads to urinary stasis (VUR in 41% cases but also renal calculi, obstructive uropathy - or family history of VUR, voiding disorders) or poor urine flow - eg, phimosis. Constipation. Impaired immune function. Sexual abuse. Impaired renal function. Presentation Symptoms include: Dysuria Frequency Urgency Nocturia Haematuria Suprapubic discomfort Signs may include: Suprapubic tenderness. Cloudy or foul-smelling urine

2008 Mentor

639. Pyelonephritis

and there is commonly pain on firm palpation of one or both kidneys and moderate suprapubic tenderness without guarding. Presentation in children, especially when young, can be much less specific and culture of urine should be a routine investigation in pyrexial and unwell infants. Differential diagnosis Abdominal abscess. . . Causes of . Causes of . . . . . . . Oophoritis. Papillary necrosis. . . Renal corticomedullary abscess. . Salpingitis. . . VUR. Vesicovaginal and ureterovaginal fistula. Investigations (...) Intercollegiate Guidelines Network - SIGN (updated July 2012) ; Public Health England, August 2015 ; Antibiotics for acute pyelonephritis in children. Cochrane Database Syst Rev. 2014 Jul 287:CD003772. doi: 10.1002/14651858.CD003772.pub4. ; Treatment and prophylaxis in pediatric urinary tract infection. Int J Prev Med. 2011 Jan2(1):4-9. ; Interventions for primary vesicoureteric reflux. Cochrane Database Syst Rev. 2011 Jun 15(6):CD001532. doi: 10.1002/14651858.CD001532.pub4. ; European Association of Urology

2008 Mentor

640. Puerperal Pyrexia

of puerperal pyrexia may include: : Frequency, dysuria, haematuria. Rigors from pyelonephritis. 95% caused by Escherichia coli , Proteus spp. and Klebsiella spp. : Tender bulky uterus. Prolonged bleeding/pink or discoloured lochia. Painful inflamed perineum. May be caused by E. coli , other anaerobes, Group A streptococcus (GAS) (also known as Streptococcus pyogenes ), Staphylococcus spp. and Clostridium welchii (rare, but serious). : Flu-like symptoms. Painful, hard, red breast with possible abscess (...) Gynecol Surv. 2007 Jun62(6):400-6. ; Oliver Wendell Holmes (1809-1894) and his essay on puerperal fever. Arch Dis Child Fetal Neonatal Ed. 2007 Jul92(4):F325-7. ; Royal College of Obstetricians and Gynaecologists (April 2012) ; Maternal sepsis: epidemiology, etiology and outcome. Curr Opin Infect Dis. 2010 Jun23(3):249-54. doi: 10.1097/QCO.0b013e328339257c. ; MBRRACE-UK, Dec 2015 ; NICE Clinical Guideline (November 2011) ; Antibiotic prophylaxis versus no prophylaxis for preventing infection after

2008 Mentor

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>